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Epidemiologically, certain human papillomaviruses are positively associated with cervical cancer, while adeno-associated
viruses (AAV-2) are negatively associated with this same cancer. Both HPV and AAV productively replicate in differentiating
keratinocytes of the skin and interact with each other. However, AAV has a relatively fast life cycle, generating infectious
progeny by the third to fourth day of an organotypic epithelial raft culture. In contrast, HPV is slow, generating infectious
progeny only after 10–12 days. As earlier studies indicated that these two skin-tropic virus types significantly affect each
other’s life cycle, we investigated if the temporal kinetics of the slow HPV life cycle was affected by the fast AAV in raft
cultures. Here it is shown that the presence of AAV-2 at a variety of multiplicities of infection (m.o.i.) resulted in early onset
HPV-31b DNA replication. Using plasmids which each expressed only one of the four rep proteins, an enhancement affect
was seen for all four rep proteins of AAV, with Rep40 having the highest activity. Furthermore, AAV (m.o.i. of 5) also resulted
in a temporally accelerated production of HPV infectious units, seen as early as Day 4, with high levels of viral progeny being
produced by Day 6.5. Like earlier studies at Day 12, histological differences were seen at Day 6.5 between AAV-infected and
mock-infected HPV/rafts. These data suggest that under specific conditions the AAV rep trans-factors can positively regulate
HPV gene expression in addition to the usual negative regulation that has been consistently observed by the rep proteins.
These data also suggest that AAV has a significant effect upon the temporal kinetics of the HPV life cycle in natural hostast HP
)INTRODUCTION
Infection and DNA integration by certain human pap-
illomavirus types (HPV) have been shown to be strongly
associated with cervical cancer (Cullen et al., 1991; Durst
et al., 1983). However, there is growing evidence that
adeno-associated virus (AAV), another virus commonly
found in the anogenital region (Bantel-Schaal and zur
Hausen, 1984; Blacklow et al., 1967; Coker et al., 2001;
Friedman-Einat et al., 1997; Han et al., 1996; Malhomme
et al., 1997; Tobiasch et al., 1995; Venturoli et al., 2001;
Walz et al., 1997, 1998), is negatively associated with
cervical cancer as demonstrated by the prevalence or
titer of anti-AAV antibodies or the presence of AAV DNA
(Coker et al., 2001; Georg-Fries et al., 1984; Mayor et al.,
1976; Smith et al., 2001). This laboratory has been ex-
ploring the hypothesis that AAV interacts with HPVs and
inhibit its role in cervical carcinogenesis. We have ob-
served AAV’s inhibition of bovine papillomavirus type 1
(BPV-1) and HPV-16-induced oncogenic transformation
and DNA replication in a number of assay systems (Her-
1 To whom reprint requests should be addressed at OB/GYN,
Slot 518, University of Arkansas for Medical Sciences, 4301 West203monat, 1989, 1992, 1994; Hermonat et al., 1997). Others
have also observed AAV inhibition of BPV-1 and HPV-
16/18 (Horer et al., 1995; Marcello et al., 2000; Schmitt et
al., 1989; Su and Wu, 1996; Wu et al., 1999). The AAV-
encoded Rep78 protein is responsible for these inhibi-
tions, and the papillomavirus promoter just upstream of
the E6 gene (P89 [BPV], P97 [HPV-16], and P105 [HPV-
18]) is one likely target (Han et al., 1999; Hermonat, 1989,
1994; Hermonat et al., 1997; Horer et al., 1995; Marcello
et al., 2000; Su et al., 2000). Rep78 is also able to inhibit
a wide variety of heterologous genes (e.g., c-H-ras [Katz
and Carter, 1986; Hermonat, 1991; Hermonat et al., 1998])
and the human immunodeficiency virus long-terminal
repeat (HIV-LTR [Batchu and Hermonat, 1995; Kokorina et
al., 1998; Rittner et al., 1992]), while other genes are not
affected (e.g., the murine osteosarcomavirus long-termi-
nal repeat [MSV-LTR] [Hermonat, 1991] and the human
-actin promoter [Horer et al., 1995]).
The most common result of AAV-papillomavirus inter-
action has usually been the inhibition of the papilloma-
virus phenotypes of transcription, oncogenic transforma-
tion, and DNA replication. However, mild enhancement
of BPV-1 oncogenic transformation and replication has
also been seen under certain conditions (Hermonat ettissue. However, it is unclear if or how this AAV-induced f
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as the host cell type. This cell type may not be suitable
as a model for viral interactions in skin or the carcino-
genesis process of squamous cancer. Because of this
we have turned to the organotypic epithelial raft culture
system, an accurate model of skin, to study the AAV-HPV
interaction. The life cycle of HPV-31b is well documented
in the raft culture system (Bedell et al., 1991; Hummel et
al., 1992; Myers et al., 1992; Ozbun and Myers, 1997).
Recently, using raft cultures we have shown that when a
low m.o.i. of AAV is used to infect a resident HPV latent
infection, HPV DNA replication is mildly enhanced (Mey-
ers et al., 2001). However, AAV at high m.o.i. will inhibit
HPV replication. Related to these studies we recently
demonstrated that AAV is an autonomous, skin-specific
parvovirus, with a similar tropism as papillomaviruses
(Meyers et al., 2000, 2001). AAV replication is also af-
fected by HPV, being moderately enhanced (Meyers et
al., 2001).
One interesting aspect of the most recent studies
done in raft cultures has been the discovery that AAV
requires only 3 to 4 days of raft culture to allow for
progeny virus formation (Meyers et al., 2000). In contrast
HPV requires 10–12 days for complete “vegetative” repli-
cation and progeny formation (Meyers et al., 1997, 1992).
Clearly as one virus type is “fast” and the other “slow,”
what temporal changes occur in the life cycle of the slow
HPV when in the presence of AAV? In this study, to
further address the AAV-papillomavirus interaction in
skin, we carry out time course experiments and find that
the presence of AAV, at low, moderate, and high m.o.i.,
stimulated a more rapid rise in HPV DNA levels (“early
onset”) as well as virion production. Genetic analysis of
the AAV rep region indicated that it is the Rep40 protein
which is most likely responsible for this temporal accel-
eration.
RESULTS
AAV infection of HPV-31b-epithelial results in early
onset HPV DNA replication
We have previously reported that AAV is able to mildly
enhance HPV DNA replication at low-moderate m.o.i.,
when the levels are measured at Day 12, at the end of
what would normally be considered the HPV life cycle
(Meyers et al., 2001). However, AAV has a much faster
replication cycle in skin than HPVs (Meyers et al., 2000).
To observe temporal differences in HPV replication we
infected CIN-612 9E cells with AAV at an m.o.i. of 0.1, 5,
and 100 at time zero, before raising the raft to the air as
depicted in Fig. 1A. Rafts were harvested at Days 4, 6.5,
9.3, and 12 for DNA and HPV-31b DNA levels analyzed by
Southern blot, as shown in Fig. 1B. As can be seen at
Day 12 HPV-31b DNA levels were relatively stable at
low/moderate AAV m.o.i.s (0.1 and 5), but then fell with a
high m.o.i. (100). However, the most significant difference
was the appearance of high levels of HPV-31b DNA seen
at early times (Days 4 and 6.5) in the presence of AAV
compared to without AAV. We referred to this effect as
“early onset” HPV-31b DNA replication. Early onset DNA
replication was observed in all five experiments under-
taken. This early onset replication was even evident with
the highest level of AAV superinfection which showed
inhibition at later times. Figure 1C shows the effects of
AAV at an m.o.i. of 5 at even earlier times, Days 2–4. The
appearance of AAV-enhanced replication was not signif-
icant until Day 4.
AAV Rep40 stimulates HPV DNA replication
The rep proteins, the nonstructural proteins of AAV,
would seem to be the likely suspects for altering HPV
replication. To map the affect of these proteins a series
of four plasmids was used, each of which expressed
either Rep78, Rep68, Rep52, or Rep40 (Horer et al., 1995).
FIG. 1. Affect of AAV superinfection on resident HPV-31b DNA levels
over time. (A) A diagrammatic representation of the experiment. CIN-
612 9E CIN I cervical biopsy cells, containing episomal HPV-31b, were
infected with AAV at various multiplicities of infection (m.o.i.) for 4 h and
then trypsinized and seeded onto collagen/J2 fibroblast rafts and raised
to the air. At various times DNA is isolated from the rafts and analyzed
for HPV-31b DNA by Southern blot. (B) The results from a representative
experiment as described in A. Note that early onset HPV-31b DNA
replication (Days 4 and 6.5) was observed at all m.o.i.s of AAV. This high
level of HPV replication is maintained at low-moderate m.o.i. of AAV.
However, at an m.o.i. of 100 HPV-31b DNA replication is inhibited over
time. (C) A similar experiment to that depicted in A and B but including
earlier times.
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The KEX-rep series of plasmids was individually trans-
fected into CIN-612 9E cells and then the cells were
treated with retinoic acid to stimulate a modicum of
keratinocyte differentiation. An AAV cap (capsid) expres-
sion plasmid was also transfected as a control. Three
transfections were done for each plasmid. This experi-
mental scheme, depicted in Fig. 2A, was used as an
inexpensive, easy substitute for the organotypic raft cul-
ture system as only DNA levels were being observed.
Retinoic acid increased HPV-31b DNA levels by 2.5-fold
by Day 4. The cells were then harvested at Day 4 and
HPV-31b DNA levels analyzed by Southern blot. The
results, shown in Fig. 2B and quantitated in Fig. 2C,
suggested that all of the four rep proteins had an en-
hancing affect on HPV-31b DNA replication. There was a
minor “plasmid effect” shown by the transfection of
dl10-37 (rep negative); however, Rep40, the smallest of
the reps, stimulated the highest level of replication.
AAV stimulates early production of HPV infectious
units
To observe if early HPV DNA replication was accom-
panied by early progeny virus production we employed a
“2 raft” experiment as depicted in Fig. 3A. In this exper-
iment CIN-612 9E cells were infected with AAV at an
m.o.i. of 5 or mock infected. However, instead of harvest-
ing DNA at various times, potential virus stocks were
generated from the rafts. Three rafts were done for each
time point. The rafts were minced, freeze-thawed three
times, and treated with DNAse I. This series of putative
virus stocks was then used to infect a second culture of
normal keratinocytes which were subsequently added
into the raft culture system. Any HPV virions produced in
the original raft would infect and replicate in the second,
FIG. 3. Affect of AAV on HPV-31b virion production over time analyzed
by a 2-plate experiment. (A) A diagrammatic representation of the
experiment. This experiment is very similar to that of Fig. 1 except that
only one m.o.i. (5) of AAV was used to infect the CIN-612 9E cells.
However, instead of isolating DNA at various times as in Fig. 1 the rafts
were minced, freeze-thawed three times, treated with DNase I, and
filtered, and an aliquot of the putative virus stock was used to infect a
second culture of normal keratinocytes which were subsequently put
into the raft culture system. Virus produced in the HPV raft would
infect and replicate in the normal skin raft. (B) The results. Note that
early onset HPV-31b virion production (Days 4 and 6.5) is taking place
in the presence of AAV. Normally, HPV-31b virion production does not
occur until Days 10–12. (C) Representative DNA from the same exper-
iment analyzed by Southern blot. Note the significant levels of HPV-31b
DNA (8 kb) are present only at Day 6.5 plus AAV.
FIG. 2. Affect of AAV rep and lip-cap genes on HPV-31b DNA repli-
cation. (A) A diagrammatic representation of the experiment. In this
experiment monolayer CIN-612 9E cells are transfected with various
AAV plasmids at Day 1, and total DNA is harvested at Day 4 and
analyzed for HPV-31b sequences by Southern blot. (B) The affect of
retinoic acid treatment on HPV-31b DNA levels in CIN-612 9E cells (a
2.5-fold increase). (C) The results from a representative experiment
described in A. Dl10-37 contains only the AAV lip-cap genes, while the
names of the other four plasmids indicate the rep protein which they
express. Note that all four rep proteins enhance HPV replication, with
Rep40 exhibiting the strongest enhancement. (D) Quantitative mea-
surements of the indicated results as determined using an IS-1000
Digital Imaging System (Alpha Innotech Corp, San Leandro, CA).
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normal keratinocyte-based raft. Because of the high
number of specimens we opted for a dot blot analysis of
the resulting DNA. The dot blotted experiment, done in
triplicate and probed for HPV-31b, is shown in Fig. 3B. As
can be seen in the mock-infected control (no AAV) sig-
nificant HPV-31b DNA levels, reflecting HPV infectious
units, were not observed until Day 12. This is consistent
with published studies on HPV-31b (Meyers et al., 1992).
In contrast, the rafts infected with AAV showed that
significant levels of HPV-31b infectious units were
present by Day 6.5. The drop in infectious units seen
after Day 6.5 plus AAV may be due to cell lysis as the
result of rapid progression of the dual AAV/HPV life cycle.
However, the effect is reproducible. Figure 3C shows
representative DNA samples from this experiment as
analyzed by Southern blot, and presents the HPV-31b
DNA as an 8-kb band as expected, and only at significant
levels on Day 6.5 with AAV. Figure 4 shows a quantitative
measurement of the HPV virus production on Day 12
without AAV versus Day 6.5 with AAV, the time of highest
virus levels under both conditions.
To verify that HPV-31b infectious units were being
produced at the early times an experiment similar to that
in Fig. 3 was undertaken except that spliced E1^E4
transcripts were observed by RT-PCR in the Days 4 and
6.5 lysate/infected second rafts. The results, as an
ethidium bromide-stained gel, and a Southern blot of this
gel probed for the E1^E4 transcript, are shown in Figs.
5A and B, respectively. Note that an appropriate sized
band (349 bases) appears at Day 6.5 by ethidium bro-
mide staining. This band was also identified by Southern
blot in the AAV lane but not in the AAV lane. The
same results, although not as strong, were observed at
Day 4. These data are consistent with Fig. 3, showing
HPV virions being generated at high levels by Day 6.5,
and at least at low levels as early as Day 4 when in the
presence of AAV.
AAV infection of epithelial rafts containing HPV-31b
results in histological change
Next, the state of differentiation of the epithelial rafts
was analyzed for changes due to AAV virus infection by
observing histologic cross sections of the epithelial rafts
at Days 4 and 6.5, the time of HPV virion production with
AAV. The rafts were processed as tissue and hematoxy-
lin/eosin stained. Representative photomicrographs are
shown in Fig. 6. As can be seen the CIN-612 9E-based
epithelium without AAV has a somewhat different ap-
pearance than that with AAV. With AAV there appears to
be eosinophilic/hyperkeratinized areas which are not
seen normally (see arrows). This may suggest that AAV
(m.o.i. 5) is causing an advance in the level of keratino-
cyte differentiation. Alternatively, AAV may be stimulating
a different differentiation pattern within the epithelium
than without AAV. In any case it is likely that these
changes are associated with the appearance of early
onset HPV31b infectious units.
DISCUSSION
Six different laboratories have demonstrated that AAV
can be found in genital epithelium (Bantel-Schaal and zur
FIG. 5. Analysis of early onset HPV infectious units by RT-PCR
analysis for spliced E1^E4 transcripts in a 2-plate experiment. These
experiments were similar to those of Fig. 3 except that poly(A) RNA was
isolated from the second plate/raft and analyzed by RT-PCR as de-
scribed under Materials and Methods. (A) The ethidium bromide-
stained gel of the RT-PCR products. (B) The Southern blot analysis of
these products, probed for E1^E4. Note that a signal can be observed
even at Day 4 with AAV.
FIG. 4. HPV infectious unit replication with and without AAV. The Day
12 minus AAV, HPV replication signal strength in Fig. 3 was densito-
metrically quantified and compared to that of Day 6.5 plus AAV signal.
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Hausen, 1984; Coker et al., 2001; Friedman-Einat et al.,
1997; Han et al., 1996; Malhomme et al., 1997; Tobiasch
et al., 1995; Venturoli et al., 2001; Walz et al., 1997, 1998).
These findings support the validity of the epidemiologic
studies showing AAV’s negative association with HPV-
associated cervical cancer (Coker et al., 2001; Georg-
Fries et al., 1984; Mayor et al., 1976; Smith et al., 2001). In
fact, AAV-5 was initially isolated from a penile condylo-
mata (Bantel-Schaal and zur Hausen, 1984; Georg-Fries
et al., 1984). However, it should also be pointed out that
two laboratories did not find AAV in the cervix (Odunsi et
al., 2000; Strickler et al., 1999). Our earlier data showing
that AAV-2 autonomously replicates in skin rafts, without
helper virus, generated from neonatal foreskin keratino-
cytes is also consistent with the possibility of genital AAV
infections (Meyers et al., 2000). This study confirms ear-
lier data that AAV has significant affects on the HPV life
cycle in natural host tissue (Meyers et al., 2001). It is
further confirmed that AAV enhances HPV-31b DNA rep-
lication at low-moderate m.o.i. and inhibits HPV-31b DNA
replication at high m.o.i. Most importantly, however, this
study demonstrates that the normal temporal life cycle of
HPV-31b is stimulated to a more rapid course by the
presence of AAV. In the presence of AAV, we show
evidence that HPV virions are produced as early as Day
4, one-third the time as “normal.” The enhancement of
HPV-31b DNA replication by AAV was mapped to the AAV
rep proteins, with Rep40 having the highest activity. This
finding was surprising as the sequences of Rep40 are a
subset of those present in the larger rep proteins Rep78,
Rep68, and Rep52. Possibly rep proteins have an “en-
hancer” domain, possibly regulating transcription, which
is present in all forms, but is only unmasked in the
smallest Rep40.
It is interesting and important to note the dual nature of
the affect of the AAV rep proteins upon papillomaviruses.
Clearly the AAV rep gene can both inhibit papillomavirus
replication (Hermonat, 1992; Marcello et al., 2000;
Schmitt et al., 1989) and enhance their replication under
different circumstances (Hermonat et al., 1998; Meyers et
al., 2001). This is also true of Rep78’s effects on its own
p5 promoter. In the presence of adenovirus Rep78 is a
strong trans-activator of p5 (Beaton et al., 1989; Kyostio et
al., 1995; Labow et al., 1986; Pereira et al., 1997; Tratschin
et al., 1986; Trempe and Carter, 1988). However, without
adenovirus Rep78 is a strong trans-inhibitor (Beaton et
al., 1989; Kyostio et al., 1995; Pereira et al., 1997). The
mechanism of this “switch” is presently unknown. The
dual nature of the rep proteins is also highlighted by a
comparison of our findings with those of Marcello et al.
(2000), in which Rep40 was found to have the strongest
trans-inhibitory activity on HPV DNA replication (Mar-
cello et al., 2000). That Rep40 is the strongest trans-
enhancer of HPV-31b DNA replication in our hands is
interesting and ironic. Superficially these results are op-
posite, and seemingly incompatible. However, knowing
Rep78’s dual affects on the p5 promoter, these opposite
results may, in fact, be mutually supportive.
What does a “quick” HPV life cycle mean for HPV
survival and what does this mean for clinical outcomes
of HPV-associated pathology? These questions cannot
currently be answered; however, several outcomes might
be speculated upon. First, it might be speculated that the
lower AAV m.o.i. situation likely represents the most
common in vivo situation. If so, then AAV might be
thought of as a “helper/enhancer” for HPV. Second, the
appearance and structure of the wart will likely be sig-
nificantly different with AAV coinfection than without. We
observe that histologic differences with AAV are present
at early times (this paper) as well as late times (Meyers
et al., 2001). We can speculate that warts might be less
exophytic (raised in height) when moderate and high
levels of AAV or present, or more exophytic when con-
taining low amounts of AAV. Third, chromosomal integra-
tion of the HPV genetic material is a critical step in the
development of the malignant phenotype. Potentially, the
promotion of HPV replication by AAV Rep40 (and other
AAV rep proteins) might have an “anti-integration” effect
as integration is likely a result of abortive or deficient
(low?) replication. Fourth, the appearance of high levels
of AAV appear to cause an erosion or loss of the upper
levels of the epithelium. Possibly this is an AAV-induced
lysis of the cells in which both AAV and HPV are present.
Normally, warts do not exhibit forms of apoptosis or cell
lysis. The death of such cells, eliminating HPV-infected
FIG. 6. Histology of early rafts. Shown are the histologic cross
sections of the epithelium at Days 4 and 6.5, with and without AAV at
an m.o.i. of 5. Note that AAV-associated changes, increased keratini-
zation (arrows), are visible compared to the control sections.
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cells, would seem to favor a better prognosis. Fifth, AAV
is known to promote keratinocyte differentiation (Klein-
Bauernschmitt et al., 1992). HPV and AAV replication are
dependent upon this differentiation (Kokorina et al., 1998;
Meyers et al., 1992, 2000, 2001). However, this effect may
also have an anti-cancer effect as cancer is usually
interpreted as a condition of dedifferentiation. Sixth, the
quicker HPV life cycle, as fast as one-third the normal
time, may simply limit the period of time that HPV can do
its damage to the epithelium, its contribution to cancer.
Seventh, the quicker life cycle of HPV, resulting in repli-
cation at a lower level in the stratified epithelium, closer
to the basement membrane, may raise HPV’s immuno-
logic profile to be more easily recognized by the host’s
immune system. Eighth, the addition of AAV’s immuno-
logic epitopes, additional foreign components, may fur-
ther target immune responses against the infected tis-
sue. In any case, findings of enhancement of HPV repli-
cation by AAV and enhancement of AAV replication by
HPV under many conditions suggest that HPV and AAV
may often be “traveling partners” during skin infection
(Meyers et al., 2000, 2001; Ogston et al., 2000).
MATERIALS AND METHODS
Organotypic epithelial raft cultures, AAV virus
infections, and analysis of HPV replication
Established monolayer CIN-612 9E CIN I cervical bi-
opsy cells (Meyers et al., 2001), containing resident la-
tent episomal HPV-31b, were superinfected with AAV at
various multiplicities of infection (0.1, 10, 100 m.o.i.) for 4 h
and then cells were trypsinized and seeded onto orga-
notypic (collagen/J2 fibroblast) rafts as previously de-
scribed (Meyers et al., 1992, 1997, 2000, 2001). The next
day raft cultures were lifted to the air liquid interface and
fed every other day with E media plus 10 m of 1,2-
dioctanoyl-sn glycerol (C8:0) (Sigma Chemical Co., St.
Louis, MO). The rafts were harvested after 4, 6.5, 9.3, and
12 days from the day of infection to observe HPV-31b
replication. To isolate total DNA from the organotypic
epithelial rafts, they were minced and incubated in 2 ml
of lysis buffer (0.5% SDS, 5 mM Tris-HCl, pH 8.0. 5 mM
EDTA, 0.5 mg/ml proteinase K) overnight at 37°C fol-
lowed by phenol extraction. The DNA was precipitated
by ethanol, Southern blotted, and probed for HPV-31b
sequences to observe the level of HPV DNA replication.
Four micrograms of total cellular DNA was electropho-
resed.
Transfection of plasmids into CIN-612 9E cells and
analysis of HPV DNA replication
CIN-612 9E cervical biopsy cells containing episomal
HPV-31b were transfected with 4 g of pGEX-rep40,
pGEX-rep68, pGEX-rep52, pGEX-rep40 separately (Horer
et al., 1995). A control plate of cells was transfected with
dl10-37(lip/cap). At Day 2 the cells were treated with
13-cis-retinoic acid (107 M) to induce a modicum of
differentiation. DNA was harvested from each plate at
Day 4, to determine the levels of HPV DNA. Four micro-
grams of total cellular DNA was electrophoresed. The
isolated DNA was electrophoresed, Southern blotted,
and probed for HPV 31b sequences.
“2 Raft” Southern and dot blot analysis for HPV virion
production
The ability of AAV to affect HPV 31b DNA and produc-
tive replication, a “2 plate” experiment as depicted in Fig.
1A was carried out. To analyze HPV-31b virus production
CIN-612 9E cells were infected with AAV at an m.o.i. of 5
and the rafts harvested on Days 4, 6.5, 9.3, and 12. The
rafts were minced, added to 2 ml of medium, and freeze-
thawed three times to generate a putative HPV viral
stock. The stocks were also filtered to remove debris and
treated with DNase I for 1 h (100 units/ml) to eliminate
any unencapsidated DNA. An aliquot (1 ml) of the viral
stock prepared from experimental as well as control rafts
was applied to the medium of submerged prerafts of
normal non-HPV-positive keratinocytes and allowed to
infect overnight. The next day the rafts were raised to the
air interface and allowed to develop for 10 days. On the
10th day the second rafts were harvested for total cellu-
lar DNA and analyzed for HPV DNA by Southern dot blot.
Any HPV virions produced in the first raft would infect the
keratinocytes of the second raft and be amplified. Due to
the number of specimens the HPV DNA levels from the
second raft were measured by dot blot hybridization. We
also analyzed representative samples by agarose gel
electrophoresis and Southern blot to determine the size
of the HPV DNA.
2 Raft RT-PCR analysis of HPV E1^E4 spliced RNA
(acceptor at nucleotide 3295)
An identical experiment to the 2 raft HPV virion pro-
duction experiment was used to observe the generation
of spliced RNAs. However, at Day 10 total RNA was
extracted from second rafts by using TRIzol reagent
(Gibco BRL, Bethesda, MD) according to manufacturer’s
protocol. Isolated total RNA was treated with RNase-free
DNase I (Promega, Madison, WI) 3 U/ml for 2 h at 37°C
and then redissolved in DEPC-treated water. Poly(A)
mRNA was isolated from total RNA by using an Oligotex
(Qiagen) kit. The reverse transcription (RT) reaction was
performed on isolated poly(A) mRNA for 2 h at 37°C. For
PCR an upstream primer (5-GCAGAACCGGACACATCC-
3) corresponding to nt 692 to 709 and a downstream
primer (5-GGTGTTTCTGTGCTCTGG-3) corresponding
to nt 3440 to nt 3457 of HPV 31b sequence were used.
The RT-PCR conditions were as described elsewhere
(Liu et al., 2000). The PCR products were analyzed on 1%
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agarose gel, photographed, and transferred onto nitro-
cellulose membrane, probed with HPV sequence.
Histochemical analysis of rafts
CIN-612 9E raft cultures with and without AAV-2 were
harvested on Days 4 and 6.5 and fixed in 10% buffered
formalin and embedded in paraffin. Cross sections 5 m
thick were cut and stained with hematoxylin and eosine
(Meyers et al., 1992, 1997, 2000, 2001).
ACKNOWLEDGMENTS
This study was funded by grants from the NIH (CA55051 and
AR48930). The authors thank Drs. Yong Liu, Krishna Prasad, and Brian
Bishop for useful discussions.
REFERENCES
Bantel-Schaal, U., and zur Hausen, H. (1984). Characterization of the
DNA of a defective human parvovirus isolated from a genital site.
Virology 134, 52–63.
Batchu, R. B., and Hermonat, P. L. (1995). The trans-inhibitory Rep78
protein of adeno-associated virus binds to TAR region DNA of the
human immunodeficiency virus type 1 long terminal repeat. FEBS
Lett. 367, 267–271.
Beaton, A., Palumbo, P., and Berns, K. I. (1989). Expression from the
adeno-associated virus p5 and p19 promoters is negatively regu-
lated in trans by the rep protein. J. Virol. 63, 4450–4454.
Bedell, M. A., Hudson, J. B., Golub, T. R., Turyk, M. E., Hosken, M.,
Wilbanks, G. D., and Laimins, L. A. (1991). Amplification of human
papillomavirus genomes in vitro is dependent on epithelial differen-
tiation. J. Virol. 65, 2254–2260.
Blacklow, N. R., Hoggan, M. D., and Rowe, W. P. (1967). Isolation of
adeno-associated viruses from man. Proc. Natl. Acad. Sci. USA 58,
1410–1415.
Coker, A. L., Russell, R. B., Bond, S., Prisi, L., Liu, Y., Mane, M., Kokorina,
N., Gerasimova, T., and Hermonat, P. L. (2001). Adeno-associated
virus is associated with lower risk of high-grade cervical neoplasia.
Exp. Mol. Pathol. 70, 83–89.
Cullen, A. P., Reid, R., Campion, M., and Lorincz, A. T. (1991). Analysis of
the physical state of different human papillomavirus DNAs in intra-
epithelial and invasive cervical neoplasm. J. Virol. 65, 606–612.
Durst, M., Gissman, H., Ikenberg, H., and zur Hausen, H. (1983). A
papillomavirus DNA from a cervical carcinoma and its prevalence in
cancer biopsy samples from different geographic regions. Proc. Natl.
Acad. Sci. USA 80, 3812–3815.
Friedman-Einat, M., Grossman, Z., Mileguir, F., Smetana, Z., Ashkenazi,
M., Barkai, G., Varsano, N., Glick, E., and Mendelson, E. (1997).
Detection of adeno-associated virus type 2 sequences in the human
genital tract. J. Clin. Microbiol. 35, 71–78.
Georg-Fries, B., Biederlack, S., Wolf, J., and zur Hausen, H. (1984).
Analysis of proteins, helper dependence, and seroepidemiology of a
human parvovirus. Virology 134, 64–71.
Han, L., Parmley, T. H., Keith, S., Kozlowski, K. J., Smith, L. J., and
Hermonat, P. L. (1996). High prevalence of adeno-associated virus
(AAV) type 2 rep DNA in cervical materials: AAV may be sexually
transmitted. Virus Genes 12, 47–52.
Hermonat, P. L. (1989). The adeno-associated virus Rep78 gene inhibits
cellular transformation induced by bovine papillomavirus. Virology
172, 253–261.
Hermonat, P. L. (1991). Inhibition of H-ras expression by the adeno-
associated virus Rep78 transformation suppressor gene product.
Can. Res. 51, 3373–3377.
Hermonat, P. L. (1992). Inhibition of bovine papillomavirus plasmid DNA
replication by adeno-associated virus. Virology 189, 329–333.
Hermonat, P. L. (1994). Adeno-associated virus inhibits human papillo-
mavirus type 16: A viral interaction implicated in cervical cancer. Can.
Res. 54, 2278–2281.
Hermonat, P. L., Meyers, C., Parham, G. P., and Santin, A. D. (1998).
Inhibition/stimulation of bovine papillomavirus by adeno-associated
virus is time as well as multiplicity dependent. Virology 267, 240–250.
Hermonat, P. L., Plott, R. T., Santin, A. D., Parham, G. P., and Flick, J. T.
(1997). The adeno-associated virus Rep78 gene inhibits oncogenic
transformation of primary keratinocytes by a human papillomavirus
type 16-ras chimeric. Gynecol. Oncol. 66, 487–494.
Horer, M., Weger, S., Butz, K., Hoppe-Seyler, F., Geisen, C., and Klein-
schmidt, J. A. (1995). Mutational analysis of adeno-associated virus
Rep protein-mediated inhibition of heterologous and homologous
promoters. J. Virol. 69, 5485–5496.
Hummel, M., Hudson, J. B., and Laimins, L. A. (1992). Differentiation-
induced and constitutive transcription of human papillomavirus type
31b in cell lines containing viral episomes. J. Virol. 66, 6070–6080.
Katz, E., and Carter, B. J. (1986). Effect of adeno-associated virus on
transformation of NIH 3T3 cells by ras gene and on tumorigenicity of
an NIH 3T3 transformed cell line. Can. Res. 46, 3023–3026.
Klein-Bauernschmitt, P., zur Hausen, H., and Schlehofer, J. R. (1992).
Induction of differentiation-associated changes in established hu-
man cells by infection with adeno-associated virus type 2. J. Virol. 66,
4191–2000.
Kokorina, N. A., Santin, A. D., Li, C., and Hermonat, P. L. (1998). Involve-
ment of protein-DNA interaction in adeno-associated virus Rep78-
mediated inhibition of HIV-1. J. Hum. Virol. 1, 441–450.
Kyostio, S. R., Wonderling, R. S., and Owens, R. A. (1995). Negative
regulation of the adeno-associated virus (AAV) P5 promoter involves
both the P5 rep binding site and the consensus ATP-binding motif of
the AAV Rep68 protein. J. Virol. 69, 6787–6796.
Labow, M. A., Hermonat, P. L., and Berns, K. I. (1986). Positive and
negative autoregulation of the adeno-associated virus type 2 ge-
nome. J. Virol. 60, 251–258.
Liu, Y., Santin, A. D., Mane, M., Chiriva-Internati, M., Parham, G. P.,
Ravaggi, A., and Hermonat, P. L. (2000). Transduction and utility of the
granulocyte-macrophage colony-stimulating factor gene into mono-
cytes and dendritic cells by adeno-associated virus. J. Interferon
Cytokine Res. 20, 21–30.
Malhomme, O., Dutheil, N., Rabreau, M., Armbruster-Moraes, E., Schle-
hofer, J. R., and Dupressoir, T. (1997). Human genital tissues contain-
ing DNA of adeno-associated virus lack DNA sequences of the
helper viruses adenovirus, herpes simplex virus or cytomegalovirus
but frequently contain human papillomavirus DNA. J. Gen. Virol. 78,
1957–1962.
Marcello, A., Massimi, P., Banks, L., and Giacca, M. (2000). Adeno-
associated virus type 2 rep protein inhibits human papillomavirus
type 16 E2 recruitment of the transcriptional coactivator p300. J. Virol.
74, 9090–9098.
Mayor, H. D., Drake, S., Stahmann, J., and Mumford, D. M. (1976).
Antibodies to adeno-associated satellite virus and herpes simplex
viruses in sera from cancer patients and normal adults. Am. J. Obstet.
Gynecol. 126, 100–105.
Meyers, C., Alam, S., Mane, M., and Hermonat, P. L. (2001). Altered
biology of adeno-associated virus type 2 and human papillomavirus
during dual infection of natural host tissue. Virology 287, 30–39.
Meyers, C., Frattini, M. G., Hudson, J. B., and Laimins, L. A. (1992).
Biosynthesis of human papillomavirus from a continuous cell line
upon epithelial differentiation. Science 257, 971–973.
Meyers, C., Mane, M., Kokorina, N., Alam, S., and Hermonat, P. L. (2000).
Ubiquitous adeno-associated virus type 2 autonomously replicates
in a model of normal skin. Virology 272, 338–346.
Meyers, C., Mayer, T. J., and Ozbun, M. A. (1997). Synthesis of infectious
human papillomavirus type 18 in differentiating epithelium trans-
fected with viral DNA. J. Virol. 71, 7381–7386.
209AAV INDUCED FAST HPV
Odunsi, K. O., van Ee, C. C., Ganesan, T. S., and Shelling, A. N. (2000).
Evaluation of the possible protective role of adeno-associated virus
type 2 infection in HPV-associated premalignant disease of the
cervix. Gynecol. Oncol. 78, 342–345.
Ogston, P., Raj, K., and Beard, P. (2000). Productive replication of
adeno-associated virus can occur in human papillomavirus type 16
(HPV-16) episome-containing keratinocytes and is augmented by the
HPV-16 E2 protein. J. Virol. 74, 3494–3504.
Ozbun, M. A., and Meyers, C. (1997). Characterization of late gene
transcripts expressed during vegetative replication of human papil-
lomavirus type 31b. J. Virol. 71, 5161–5172.
Pereira, D. J., McCarty, D. M., and Muzyczka, N. (1997). The adeno-
associated virus (AAV) Rep protein acts as both a repressor and an
activator to regulate AAV transcription during a productive infection.
J. Virol. 71, 1079–1088.
Rittner, K., Heilbronn, R., Kleinschmidt, J. A., and Sczakiel, G. (1992).
Adeno-associated virus type 2-mediated inhibition of human immu-
nodeficiency virus type 1 (HIV-1) replication: Involvement of p78rep/
p68rep and the HIV-1 long terminal repeat. J. Gen. Virol. 73, 2977–
2981.
Schmitt, J., Schlehofer, J. R., Mergener, K., Gissman, L., and zur Hausen,
H. (1989). Amplification of bovine papillomavirus dNA by N-methyl-
N-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with
herpes simplex virus. Virology 172, 73–81.
Smith, J., Herrero, R., Erles, K., Grimm, D., Munoz, N., Bosch, F. X., Tafur,
L., Shah, K. V., and Schlehofer, J. R. (2001). Adeno-associated virus
seropositivity and HPV-induced cervical cancer in Spain and Colum-
bia. Int. J. Cancer 94, 520–526.
Strickler, H. D., Viscidi, R., Escoffery, C., Rattray, C., Kotloff, K. L.,
Goldberg, J., Manns, A., Rabkin, C., Daniel, R., Hanchard, B., Brown,
C., Hutchinson, M., Zanizer, D., Palefsky, J., Burk, R. D., Cranston, B.,
Clayman, B., and Shah, K. V. (1999). Adeno-associated virus and
development of cervical neoplasia. J. Med. Virol. 59, 60–65.
Su, P. F., Chiang, S. Y., Wu, C. W., and Wu, F. Y. (2000). Adeno-associated
virus major Rep78 protein disrupts binding of TATA-binding protein to
the p97 promoter of human papillomavirus type 16. J. Virol. 74,
2459–2465.
Su, P. F., and Wu, F. Y. (1996). Differential suppression of the tumorige-
nicity of HeLa and SiHa cells by adeno-associated virus. Br. J. Can.
73, 1533–1537.
Tratschin, J. D., Tal, J., and Carter, B. J. (1986). Negative and positive
regulation in trans of gene expression from adeno-associated virus
vectors in mammalian cells by a viral rep gene product. Mol. Cell.
Biol. 6, 2884–2894.
Trempe, J. P., and Carter, B. J. (1988). Regulation of adeno-associated
virus gene expression in 293 cells: Control of mRNA abundance and
translation. J. Virol. 62, 68–74.
Tobiasch, E., Rabreau, M., Geletneky, K., Larue-Charlus, S., Severin, F.,
Becker, N., and Schlehofer, J. R. (1995). Detection of adeno-associ-
ated virus DNA in human genital tissue and in material from spon-
taneous abortion. J. Med. Virol. 44, 215–222.
Venturoli, S., Cricca, M., Bonvicini, F., Gallinella, G., Gentilomi, G.,
Zerbini, M., and Musiani, M. (2001). Detection of adeno-associated
virus DNA in female genital samples by PCR-ELISA. J. Med. Virol. 64,
577–582.
Walz, C., Deprez, A., Dupressoir, T., Durst, M., Rabreau, M., and Schle-
hofer, J. R. (1997). Interaction of human papillomavirus type 16 and
adeno-associated virus type 2 co-infecting human cervical epithe-
lium. J. Gen. Virol. 78, 1441–1452.
Walz, C. M., Anisi, T. R., Schlehofer, J. R., Gissmann, L., Schneider, A.,
and Muller, M. (1998). Detection of infectious adeno-associated virus
particles in human cervical biopsies. Virology 247, 97–105.
Wu, F. Y., Wu, C. Y., Lin, C. H., and Wu, C. H. (1999). Suppression of
tumorigenicity in cervical carcinoma HeLa cells by an episomal form
of adeno-associated virus. Int. J. Oncol. 15, 101–106.
Zhan, D.-J., Santin, A. D., Parham, G. P., Li, C., Meyers, C., and Her-
monat, P. L. (1999). Binding of the human papillomavirus type 16 p97
promoter by adeno-associated virus (AAV) Rep78 major regulatory
protein correlates with inhibition. J. Biol. Chem. 274, 31619–31624.
210 AGRAWAL ET AL.
